Bonsai Health, a San Francisco, CA-based AI-powered platform designed to transform healthcare with agentic AI, has raised $7 million in Seed funding. 

Investors 

The round was led by Bonfire Ventures and Wonder Ventures. 

Bonfire Ventures is a Los Angeles-based venture capital firm focused exclusively on funding early-stage B2B (business-to-business) software companies. The firm manages over $1 billion in total assets across its various funds. Bonfire is primarily a seed-stage investor, aiming to be the lead investor in each round. 

Wonder Ventures is an early-stage venture capital firm that invests in technology companies within Southern California/Los Angeles. Its mission is to back "LA's best founders earlier than anyone else." Founded in 2014, Wonder is sector-agnostic within the technology space, with investments spanning consumer, B2B, FinTech, marketplaces, logistics, and more. 

Bonsai Health Use of Funds 

The company will use the funding to expand its specialty-trained AI agents, enter new medical specialties, and scale commercialization efforts nationwide. 

About Bonsai Health 

Founded in 2024 by Travis Schneider and Luke Kervin, Bonsai Health is an agentic AI platform that deploys specialty-trained autonomous agents to automate front-office operations, including identifying care needs, engaging patients with personalized outreach, and scheduling appointments seamlessly. Bonsai leverages AI to mine practice data and automate a wide range of front-office workflows. It integrates with practice systems to reduce administrative burden. Since its launch, Bonsai has engaged over 235,000 patients across over 100 healthcare groups and specialty practices, scheduling over 36,000 appointments. 

Funding Details 

Company: Bonsai Health, Inc. 

Raised: $7.0M 

Round: Seed 

Funding Date: September 2025 

Lead Investors: Bonfire Ventures, Wonder Ventures 

Additional Investors:  

Company Website: https://bonsaihealth.com/  

Software Category: Healthcare AI / Practice Automation 

Source: https://www.businesswire.com/news/home/20250925874566/en/